Literature DB >> 25351576

MicroRNA induced cardiac reprogramming in vivo: evidence for mature cardiac myocytes and improved cardiac function.

Tilanthi M Jayawardena1, Elizabeth A Finch1, Lunan Zhang1, Hengtao Zhang1, Conrad P Hodgkinson1, Richard E Pratt1, Paul B Rosenberg1, Maria Mirotsou1, Victor J Dzau2.   

Abstract

RATIONALE: A major goal for the treatment of heart tissue damaged by cardiac injury is to develop strategies for restoring healthy heart muscle through the regeneration and repair of damaged myocardium. We recently demonstrated that administration of a specific combination of microRNAs (miR combo) into the infarcted myocardium leads to direct in vivo reprogramming of noncardiac myocytes to cardiac myocytes. However, the biological and functional consequences of such reprogramming are not yet known.
OBJECTIVE: The aim of this study was to determine whether noncardiac myocytes directly reprogrammed using miRNAs in vivo develop into mature functional cardiac myocytes in situ, and whether reprogramming leads to improvement of cardiac function. METHODS AND
RESULTS: We subjected fibroblast-specific protein 1-Cre mice/tandem dimer Tomato (tdTomato) mice to cardiac injury by permanent ligation of the left anterior descending coronary artery and injected lentiviruses encoding miR combo or a control nontargeting miRNA. miR combo significantly increased the number of reprogramming events in vivo. Five to 6 weeks after injury, morphological and physiological properties of tdTomato(-) and tdTomato(+) cardiac myocyte-like cells were analyzed ex vivo. tdTomato(+) cells expressed cardiac myocyte markers, sarcomeric organization, excitation-contraction coupling, and action potentials characteristic of mature ventricular cardiac myocytes (tdTomato(-) cells). Reprogramming was associated with improvement of cardiac function, as analyzed by serial echocardiography. There was a time delayed and progressive improvement in fractional shortening and other measures of ventricular function, indicating that miR combo promotes functional recovery of damaged myocardium.
CONCLUSIONS: The findings from this study further validate the potential use of miRNA-mediated reprogramming as a therapeutic approach to promote cardiac regeneration after myocardial injury.
© 2014 American Heart Association, Inc.

Entities:  

Keywords:  cellular reprogramming; excitation–contraction coupling; guided tissue regeneration; microRNAs; myocardial infarction; myocytes, cardiac

Mesh:

Substances:

Year:  2014        PMID: 25351576      PMCID: PMC4312531          DOI: 10.1161/CIRCRESAHA.116.304510

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  16 in total

1.  STIM1-Ca(2+) signaling is required for the hypertrophic growth of skeletal muscle in mice.

Authors:  Tianyu Li; Elizabeth A Finch; Victoria Graham; Zhu-Shan Zhang; Jin-Dong Ding; Jarrett Burch; Masatsugu Oh-hora; Paul Rosenberg
Journal:  Mol Cell Biol       Date:  2012-05-29       Impact factor: 4.272

2.  LNA-mediated microRNA silencing in non-human primates.

Authors:  Joacim Elmén; Morten Lindow; Sylvia Schütz; Matthew Lawrence; Andreas Petri; Susanna Obad; Marie Lindholm; Maj Hedtjärn; Henrik Frydenlund Hansen; Urs Berger; Steven Gullans; Phil Kearney; Peter Sarnow; Ellen Marie Straarup; Sakari Kauppinen
Journal:  Nature       Date:  2008-03-26       Impact factor: 49.962

3.  Reprogramming of human fibroblasts toward a cardiac fate.

Authors:  Young-Jae Nam; Kunhua Song; Xiang Luo; Edward Daniel; Kaleb Lambeth; Katherine West; Joseph A Hill; J Michael DiMaio; Linda A Baker; Rhonda Bassel-Duby; Eric N Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-04       Impact factor: 11.205

Review 4.  Induced regeneration--the progress and promise of direct reprogramming for heart repair.

Authors:  Russell C Addis; Jonathan A Epstein
Journal:  Nat Med       Date:  2013-07       Impact factor: 53.440

5.  Dynamic regulation of sarcoplasmic reticulum Ca(2+) stores by stromal interaction molecule 1 and sarcolipin during muscle differentiation.

Authors:  Malini Seth; Tianyu Li; Victoria Graham; Jarrett Burch; Elizabeth Finch; Jonathan A Stiber; Paul B Rosenberg
Journal:  Dev Dyn       Date:  2012-04       Impact factor: 3.780

6.  Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors.

Authors:  Masaki Ieda; Ji-Dong Fu; Paul Delgado-Olguin; Vasanth Vedantham; Yohei Hayashi; Benoit G Bruneau; Deepak Srivastava
Journal:  Cell       Date:  2010-08-06       Impact factor: 41.582

7.  S100A4 is upregulated in injured myocardium and promotes growth and survival of cardiac myocytes.

Authors:  Mikael Schneider; Sawa Kostin; Claes C Strøm; Mark Aplin; Stig Lyngbaek; Juliane Theilade; Mariam Grigorian; Claus B Andersen; Eugene Lukanidin; Jakob Lerche Hansen; Søren P Sheikh
Journal:  Cardiovasc Res       Date:  2007-04-06       Impact factor: 10.787

8.  Adolescent feline heart contains a population of small, proliferative ventricular myocytes with immature physiological properties.

Authors:  Xiongwen Chen; Rachel M Wilson; Hajime Kubo; Remus M Berretta; David M Harris; Xiaoying Zhang; Naser Jaleel; Scott M MacDonnell; Claudia Bearzi; Jochen Tillmanns; Irina Trofimova; Toru Hosoda; Federico Mosna; Leanne Cribbs; Annarosa Leri; Jan Kajstura; Piero Anversa; Steven R Houser
Journal:  Circ Res       Date:  2007-02-01       Impact factor: 17.367

9.  Heart repair by reprogramming non-myocytes with cardiac transcription factors.

Authors:  Kunhua Song; Young-Jae Nam; Xiang Luo; Xiaoxia Qi; Wei Tan; Guo N Huang; Asha Acharya; Christopher L Smith; Michelle D Tallquist; Eric G Neilson; Joseph A Hill; Rhonda Bassel-Duby; Eric N Olson
Journal:  Nature       Date:  2012-05-13       Impact factor: 49.962

10.  In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes.

Authors:  Li Qian; Yu Huang; C Ian Spencer; Amy Foley; Vasanth Vedantham; Lei Liu; Simon J Conway; Ji-dong Fu; Deepak Srivastava
Journal:  Nature       Date:  2012-05-31       Impact factor: 49.962

View more
  91 in total

Review 1.  Engineering Cell Fate for Tissue Regeneration by In Vivo Transdifferentiation.

Authors:  I de Lázaro; K Kostarelos
Journal:  Stem Cell Rev Rep       Date:  2016-02       Impact factor: 5.739

Review 2.  Extracellular Matrix and Regenerative Therapies from the Cardiac Perspective.

Authors:  Arin Dogan; Mahmut Parmaksız; A Eser Elçin; Y Murat Elçin
Journal:  Stem Cell Rev Rep       Date:  2016-04       Impact factor: 5.739

Review 3.  Cardiac fibrosis: potential therapeutic targets.

Authors:  Shuin Park; Ngoc B Nguyen; Arash Pezhouman; Reza Ardehali
Journal:  Transl Res       Date:  2019-03-09       Impact factor: 7.012

4.  Cardiac reprogramming factor Gata4 reduces postinfarct cardiac fibrosis through direct repression of the profibrotic mediator snail.

Authors:  Megumi Mathison; Vivek P Singh; Deepthi Sanagasetti; Lina Yang; Jaya Pratap Pinnamaneni; Jianchang Yang; Todd K Rosengart
Journal:  J Thorac Cardiovasc Surg       Date:  2017-06-21       Impact factor: 5.209

Review 5.  Discovery and progress of direct cardiac reprogramming.

Authors:  Hidenori Kojima; Masaki Ieda
Journal:  Cell Mol Life Sci       Date:  2017-02-14       Impact factor: 9.261

6.  In situ reprogramming to transdifferentiate fibroblasts into cardiomyocytes using adenoviral vectors: Implications for clinical myocardial regeneration.

Authors:  Megumi Mathison; Vivek P Singh; Maria J Chiuchiolo; Deepthi Sanagasetti; Yun Mao; Vivekkumar B Patel; Jianchang Yang; Stephen M Kaminsky; Ronald G Crystal; Todd K Rosengart
Journal:  J Thorac Cardiovasc Surg       Date:  2016-09-23       Impact factor: 5.209

Review 7.  Developing miRNA therapeutics for cardiac repair in ischemic heart disease.

Authors:  Kai Zhu; Dingqian Liu; Hao Lai; Jun Li; Chunsheng Wang
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

Review 8.  Improving cardiac reprogramming for heart regeneration.

Authors:  Liu Liu; Ienglam Lei; Zhong Wang
Journal:  Curr Opin Organ Transplant       Date:  2016-12       Impact factor: 2.640

Review 9.  Molecular discoveries and treatment strategies by direct reprogramming in cardiac regeneration.

Authors:  John H Werner; John H Rosenberg; John Y Um; Michael J Moulton; Devendra K Agrawal
Journal:  Transl Res       Date:  2018-07-31       Impact factor: 7.012

10.  Heart regeneration in mouse and human: A bioengineering perspective.

Authors:  Barry Fine; Gordana Vunjak-Novakovic
Journal:  Curr Opin Physiol       Date:  2020-01-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.